MEDISTIM ASA (MEDI.OL) Stock Earnings & Estimates
OSL:MEDI - NO0010159684 - Common Stock
265 NOK
+4 (+1.53%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 491.937M 15.13% | 526.364M 7.00% | 562.599M 6.88% | 655.86M 16.58% | 706.86M 7.78% | 762.96M 7.94% | |
| EBITDA YoY % growth | 164.539M 17.78% | 155.099M -5.74% | 155.586M 0.31% | 157.08M 0.96% | 167.28M 6.49% | 190.85M 14.09% | |
| EBIT YoY % growth | 141.251M 21.48% | 131.442M -6.94% | 131.076M -0.28% | 173.4M 32.29% | 187.68M 8.24% | 204M 8.70% | |
| Operating Margin | 28.71% | 24.97% | 23.30% | 26.44% | 26.55% | 26.74% | |
| EPS YoY % growth | N/A 0.86% | 5.67 -4.81% | N/A 7.04% | 7.10 16.97% | 7.81 10.06% | 8.48 8.49% |
All data in NOK
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in NOK
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 1.16 11.54% | 1.47 | -0.31 | -21.02% |
| Q3 2024 Q2Q % growth | 1.28 -10.49% | 1.57 | -0.29 | -18.51% |
| Q2 2024 Q2Q % growth | 1.90 5.56% | 1.50 | 0.40 | 26.72% |
| Q4 2023 Q2Q % growth | 1.04 -41.57% | 1.46 | -0.42 | -28.70% |
| Q3 2023 Q2Q % growth | 1.43 5.93% | 1.54 | -0.11 | -7.15% |
| Q2 2023 Q2Q % growth | 1.80 -0.55% | 1.52 | 0.28 | 18.44% |
| Q1 2023 Q2Q % growth | 1.40 | 1.53 | -0.13 | -8.50% |
| Q4 2022 Q2Q % growth | 1.78 -68.50% | 1.44 | 0.34 | 23.77% |
| Q3 2022 Q2Q % growth | 1.35 | 1.34 | 0.01 | 1.03% |
| Q2 2022 Q2Q % growth | 1.81 | 1.43 | 0.38 | 26.75% |
| Q4 2021 Q2Q % growth | 45.41% | 5.65 | % | |
| Q4 2020 Q2Q % growth | -7.52% | 3.89 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 169.076M 16.67% | % | ||
| Q1 2025 Q2Q % growth | 181.547M 35.70% | % | ||
| Q4 2024 Q2Q % growth | 151.139M 11.44% | 138.72M | 12.419M | 8.95% |
| Q3 2024 Q2Q % growth | 132.755M 6.98% | 138.72M | -5.965M | -4.30% |
| Q2 2024 Q2Q % growth | 144.917M 5.48% | 137.7M | 7.217M | 5.24% |
| Q1 2024 Q2Q % growth | 133.788M 3.50% | % | ||
| Q4 2023 Q2Q % growth | 135.618M -4.38% | 133.62M | 1.998M | 1.50% |
| Q3 2023 Q2Q % growth | 124.098M 6.53% | 139.74M | -15.642M | -11.19% |
| Q2 2023 Q2Q % growth | 137.386M 16.93% | 138.72M | -1.334M | -0.96% |
| Q1 2023 Q2Q % growth | 129.261M 11.31% | 130.56M | -1.299M | -0.99% |
| Q4 2022 Q2Q % growth | 141.823M 25.80% | 130.56M | 11.263M | 8.63% |
| Q3 2022 Q2Q % growth | 116.49M 14.05% | 123.42M | -6.93M | -5.61% |
| Q2 2022 Q2Q % growth | 117.495M 7.04% | 131.58M | -14.085M | -10.70% |
| Q1 2022 Q2Q % growth | 116.129M 13.15% | % | ||
| Q4 2021 Q2Q % growth | 112.74M 19.70% | 514.605M | -401.865M | -78.09% |
| Q3 2021 Q2Q % growth | 102.138M 22.52% | % | ||
| Q2 2021 Q2Q % growth | 109.768M 33.08% | % | ||
| Q1 2021 Q2Q % growth | 102.63M -0.46% | % | ||
| Q4 2020 Q2Q % growth | 94.185M -1.56% | 409.045M | -314.86M | -76.97% |
| Q3 2020 Q2Q % growth | 83.361M -2.52% | % | ||
| Q2 2020 Q2Q % growth | 82.482M -12.06% | % | ||
| Q1 2020 Q2Q % growth | 103.106M 16.19% | % | ||
| Q4 2019 Q2Q % growth | 95.673M | 372.505M | -276.832M | -74.32% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 21.47% | 21.47% |
| Revenue | N/A | N/A | 6.81% | 6.81% |